Developing Biomedical products with French Company to Combat Pandemic Covid -19 and Post Covid-19 era.
|

Developing Biomedical products with French Company to Combat Pandemic Covid -19 and Post Covid-19 era.

  Working Together Developing Biomedical Product(s) to Combat COVID 19. Ruhvenile Biomedical, India, and RNA SMART HEALTH, Paris, France, have been collaborating to develop RNA-based therapeutics to combat COVID-19 and future infectious pandemic. This collaboration aims to provide engineered antibodies…

Developing Novel Therapeutics with National and International Research Institutes to Combat COVID-19 and Future Pandemics.
|

Developing Novel Therapeutics with National and International Research Institutes to Combat COVID-19 and Future Pandemics.

  Multidisciplinary, collaborative work with International Centre for Genetic Engineering and Biotechnology (New Delhi, India, and Trieste, Italy) A team, comprising Arockiasamy Arulandu, Sujatha Sunil, and Alessandro Marcello, together with Ruhvenile Biomedical OPC Pvt. Ltd., India, working to develop novel therapeutics against COVID-19, through…

Indigenous antimicrobial product to protect front line health workers and stop transmission developed by Ruhvenile Biomedical
|

Indigenous antimicrobial product to protect front line health workers and stop transmission developed by Ruhvenile Biomedical

  In-house, indigenous antimicrobia compound-discovered and developed. For the last four years, M/s Ruhvenile Biomedical OPC Private Limited., based in New Delhi, India, has been extensively screening small organic compounds to identify non-toxic, non-ionic candidate compounds with validated enveloped-viruses deactivation…